SCHEMBL8949663

SCHEMBL8949663

COC(=O)c1c(C)nc(C(C)C)c(C(=O)O)c1-c1ccc(F)cc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GCGR P47871 7/20 0.61
SMN1; SMN2 Q16637 3/20 0.47
ABCG2 Q9UNQ0 1/20 0.46
KDM4E B2RXH2 2/20 0.46
NPC1 O15118 2/20 0.45
RAB9A P51151 2/20 0.45
CASP3 P42574 1/20 0.45
SENP8 Q96LD8 1/20 0.45
SENP7 Q9BQF6 1/20 0.45
SENP6 Q9GZR1 1/20 0.45
MEN1 O00255 1/20 0.43
KMT2A Q03164 1/20 0.43
DHODH Q02127 1/20 0.43
GAA P10253 2/20 0.41
POLB P06746 1/20 0.41
LMNA P02545 2/20 0.41
ALDH1A1 P00352 1/20 0.41
MAPT P10636 1/20 0.41
HPGD P15428 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9870958 0.91 GCGR (0.72) GCGRSMN1; SMN2NPC1RAB9ACASP3
SCHEMBL27293870 0.90 GCGR (0.49) GCGRFABP3FABP4FABP5DPP4
SCHEMBL9737768 0.87 GCGR (0.64) GCGRSMN1; SMN2ABCG2KDM4ENPC1
SCHEMBL6565362 0.86 GCGR (0.79) GCGRSMN1; SMN2NPC1RAB9ACASP3
SCHEMBL2651071 0.84 GCGR (0.56) GCGRFABP3FABP4FABP5DPP4
SCHEMBL9870560 0.84 GCGR (0.50) GCGRSMN1; SMN2NPC1RAB9ACASP3
SCHEMBL9745151 0.82 GCGR (0.60) GCGRSMN1; SMN2ABCG2NPC1RAB9A
SCHEMBL9870499 0.82 GCGR (0.47) GCGRFABP3FABP4FABP5DPP4
SCHEMBL5102048 0.82 GCGR (0.70) GCGRSMN1; SMN2ABCG2KDM4ENPC1
SCHEMBL5098308 0.80 GCGR (0.50) GCGRFABP3FABP4FABP5DPP4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5502057-A Polysubstituted pyridines useful for treating lipoproteinanaemia and arteriosclerosis BAYER AKTIENGESELLSCHAFT (DE) 1996-03-26 US disclosed
US-5470982-A Disubstituted pyridines BAYER AKTIENGESELLSCHAFT (DE) 1995-11-28 US disclosed
US-5401746-A FOR INHIBITING CHOLESTEROL BIOSYNTHESIS AND HMG-COA REDUCTASE BAYER AKTIENGESELLSCHAFT (DE) 1995-03-28 US disclosed
US-5169857-A Anticholesterol agents BAYER AKTIENGESELLSCHAFT (DE) 1992-12-08 US disclosed
US-4968689-A Certain 2,6-diisopropyl-4-(4-fluoro-phenyl)-3,5-bis-dimethyl-3',5'-dihydroxy-hept-6-enoate-pyridine derivatives useful for treating lipoproteinaemia and arteriosclerosis BAYER AKTIENGESELLSCHAFT (DE) 1990-11-06 US disclosed